Expression of ERalpha and ERbeta in lobular carcinoma in situ.
about
Isoflavones are safe compounds for therapeutical applications - evaluation of in vitro data.Estrogen receptor expression in atypical hyperplasia: lack of association with breast cancer.Biologic characteristics of premalignant breast disease.Estrogen receptor beta 2 is associated with poor prognosis in estrogen receptor alpha-negative breast carcinoma.
P2860
Expression of ERalpha and ERbeta in lobular carcinoma in situ.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Expression of ERalpha and ERbeta in lobular carcinoma in situ.
@en
type
label
Expression of ERalpha and ERbeta in lobular carcinoma in situ.
@en
prefLabel
Expression of ERalpha and ERbeta in lobular carcinoma in situ.
@en
P2093
P2860
P1433
P1476
Expression of ERalpha and ERbeta in lobular carcinoma in situ.
@en
P2093
Middleton LP
Perkins GH
Singletary SE
P2860
P304
P356
10.1111/J.1365-2559.2007.02689.X
P577
2007-06-01T00:00:00Z